Low prevalence of glucose intolerance in racially mixed children with cystic fibrosis
Article first published online: 8 FEB 2010
© 2010 John Wiley & Sons A/S
Volume 11, Issue 7, pages 493–497, November 2010
How to Cite
Alves, C., Lima, D. S., Cardeal, M. and Santana, A. (2010), Low prevalence of glucose intolerance in racially mixed children with cystic fibrosis. Pediatric Diabetes, 11: 493–497. doi: 10.1111/j.1399-5448.2010.00639.x
- Issue published online: 8 FEB 2010
- Article first published online: 8 FEB 2010
- Submitted 5 December 2009. Accepted for publication 21 December 2009
- cystic fibrosis;
- diabetes mellitus;
- glucose intolerance;
Alves C, Lima DS, Cardeal M, Santana A. Low prevalence of glucose intolerance in racially mixed children with cystic fibrosis.
Objective: To evaluate glucose tolerance in racially mixed Brazilian youth with cystic fibrosis (CF).
Methods: Cross-sectional study conducted between August and September 2007, at a reference service for CF, evaluating: glycated hemoglobin (HbA1c), blood glucose, and insulin levels, before and 2 h after a glucose overload.
Results: There were 46 patients aged between 6 yr and 16 yr and 2 months (median: 9 yr and 10 months) of whom 64% were boys. Of these, 26% were Whites; 54.4% Mulattoes; and 19.6% Blacks. HbA1c was normal in all patients. Only one participant (12-yr old) had glucose intolerance. Insulin levels ranged from 1 to 23 µIU/mL (median: 4.5 µIU/mL) at baseline and from 3.2 to 192.1 µIU/mL (median: 11 µIU/mL) after a glucose overload. Insulin resistance evaluated by the HOMA index, stratified by sex and age, was present in three patients. The ΔF508 mutation was present in only 4.3% of the sample, all of them being heterozygous.
Conclusions: The low prevalence of carbohydrate intolerance in this population is probably a result of their young age. Another possibility is the low frequency of the ΔF508 mutation. Although not conclusive, these data suggest that in addition to age, the genotype:phenotype ratio may influence the development of glucose intolerance in patients with CF.